Ko DK - Search Results

1

Cloning and characterization of the UDP-sugar hydrolase gene (ushA) of Enterobacter aerogenes IFO 12010.

Lee KS, Song SB, Kim KE, Kim YH, Kim SK, Kho BH, Ko DK, Choi YK, Lee YK, Kim CK, Kim YC, Lim JY, Kim Y, Min KH, Wanner BL. Lee KS, et al. Among authors: ko dk. Biochem Biophys Res Commun. 2000 Mar 16;269(2):526-31. doi: 10.1006/bbrc.2000.2328. Biochem Biophys Res Commun. 2000. PMID: 10708587

2

Cooperation between ZEB2 and Sp1 promotes cancer cell survival and angiogenesis during metastasis through induction of survivin and VEGF.

Ko D, Kim S. Ko D, et al. Oncotarget. 2017 Dec 11;9(1):726-742. doi: 10.18632/oncotarget.23139. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416649 Free PMC article.

3

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.

Lee Y, Ko D, Yoon J, Lee Y, Kim S. Lee Y, et al. J Exp Clin Cancer Res. 2021 Mar 1;40(1):58. doi: 10.1186/s13046-021-01828-7. J Exp Clin Cancer Res. 2021. PMID: 33641663 Free PMC article.

4

TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.

Lee Y, Yoon J, Ko D, Yu M, Lee S, Kim S. Lee Y, et al. J Exp Clin Cancer Res. 2021 Nov 22;40(1):372. doi: 10.1186/s13046-021-02147-7. J Exp Clin Cancer Res. 2021. PMID: 34809669 Free PMC article.

5

Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.

Kim S, Ko D, Lee Y, Jang S, Lee Y, Lee IY, Kim S. Kim S, et al. Sci Rep. 2019 Jul 10;9(1):10003. doi: 10.1038/s41598-019-46447-7. Sci Rep. 2019. PMID: 31292507 Free PMC article.

6

TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.

Lee Y, Ko D, Min HJ, Kim SB, Ahn HM, Lee Y, Kim S. Lee Y, et al. Oncotarget. 2016 Aug 2;7(31):50315-50332. doi: 10.18632/oncotarget.10382. Oncotarget. 2016. PMID: 27385093 Free PMC article.

7

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.

Ahn HM, Ryu J, Song JM, Lee Y, Kim HJ, Ko D, Choi I, Kim SJ, Lee JW, Kim S. Ahn HM, et al. Theranostics. 2017 Jan 11;7(3):594-613. doi: 10.7150/thno.15629. eCollection 2017. Theranostics. 2017. PMID: 28255353 Free PMC article.

8

Bovine Serum Albumin-Immobilized Black Phosphorus-Based γ-Fe₂O₃ Nanocomposites: A Promising Biocompatible Nanoplatform.

Naskar A, Lee S, Ko D, Kim S, Kim KS. Naskar A, et al. Biomedicines. 2021 Jul 22;9(8):858. doi: 10.3390/biomedicines9080858. Biomedicines. 2021. PMID: 34440062 Free PMC article.

9

Bioconjugated Thymol-Zinc Oxide Nanocomposite as a Selective and Biocompatible Antibacterial Agent against Staphylococcus Species.

Shin J, Naskar A, Ko D, Kim S, Kim KS. Shin J, et al. Int J Mol Sci. 2022 Jun 17;23(12):6770. doi: 10.3390/ijms23126770. Int J Mol Sci. 2022. PMID: 35743214 Free PMC article.

10

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models.

Ko D, Kim E, Shin EA, Nam SH, Yoon J, Lee JS, Lee Y, Park S, Ha K, Choi SY, Lee JW, Kim S. Ko D, et al. Mol Ther Oncolytics. 2022 Jan 31;24:452-466. doi: 10.1016/j.omto.2022.01.006. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35211652 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters